A detailed history of Hexagon Capital Partners LLC transactions in Organon & Co. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 2,920 shares of OGN stock, worth $42,924. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,920
Previous 2,654 10.02%
Holding current value
$42,924
Previous $54,000 1.85%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$18.65 - $23.03 $4,960 - $6,125
266 Added 10.02%
2,920 $55,000
Q2 2024

Jul 12, 2024

BUY
$17.45 - $21.96 $453 - $570
26 Added 0.99%
2,654 $54,000
Q1 2024

Apr 18, 2024

BUY
$13.78 - $18.8 $20,036 - $27,335
1,454 Added 123.85%
2,628 $49,000
Q4 2023

Feb 05, 2024

BUY
$10.95 - $17.32 $10,785 - $17,060
985 Added 521.16%
1,174 $16,000
Q3 2023

Oct 23, 2023

SELL
$16.59 - $23.77 $6,320 - $9,056
-381 Reduced 66.84%
189 $3,000
Q2 2023

Jul 24, 2023

SELL
$19.27 - $24.63 $6,609 - $8,448
-343 Reduced 37.57%
570 $11,000
Q1 2023

Apr 24, 2023

BUY
$21.42 - $32.08 $1,006 - $1,507
47 Added 5.43%
913 $21,000
Q4 2022

Jan 13, 2023

SELL
$23.31 - $28.61 $28,368 - $34,818
-1,217 Reduced 58.43%
866 $0
Q3 2022

Oct 17, 2022

BUY
$23.4 - $34.25 $29,554 - $43,257
1,263 Added 154.02%
2,083 $49,000
Q1 2022

Apr 13, 2022

SELL
$30.45 - $39.36 $182 - $236
-6 Reduced 0.73%
820 $29,000
Q4 2021

Jan 27, 2022

SELL
$28.67 - $37.13 $1,089 - $1,410
-38 Reduced 4.4%
826 $25,000
Q3 2021

Nov 12, 2021

BUY
$28.63 - $35.64 $14,000 - $17,427
489 Added 130.4%
864 $28,000
Q2 2021

Aug 11, 2021

BUY
$28.45 - $38.0 $10,668 - $14,250
375 New
375 $11,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.74B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.